Strengthening hepatitis B screening and care in Phichit Province
Treatments studied
Part of Digestive system, Infections clinical trials.
This study aims to improve screening for hepatitis B, connect people with care, and provide long-term monitoring for those affected. It uses a 'birth cohort' approach, focusing on adults born before 1992 in Phichit Province, Thailand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born before January 1, 1992 (age 34 or older).
- You live in Phichit Province, Thailand.
- You have tested positive for hepatitis B (HBsAg test) or you are willing to be tested as part of this study.
- If you are already receiving care for hepatitis B, you can also join for long-term monitoring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study follows patients who completed a previous trial of peginterferon alfa-2b and tenofovir for chronic hepatitis B. It checks long-term health and offers further treatment options based on your response to the earlier therapy.
This study tests whether a smartphone app called HBVCare helps patients with chronic hepatitis B stick to their treatment plans. Researchers will track how well the app helps patients take their medicines on time and understand what makes treatment adherence easier or harder.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
This study looks at long-term outcomes in people with chronic hepatitis B who take antiviral medicines or receive interferon. It may help doctors understand which treatments work best over time and who is most likely to benefit.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.